Today, Petros Pharmaceuticals Inc Inc’s (NASDAQ: PTPI) stock fell $0.21, accounting for a 8.40% decrease. Petros opened at $2.48 before trading between $2.60 and $2.23 throughout Wednesday’s session. The activity saw Petros’s market cap fall to $22,438,018 on 44,833 shares -below their 30-day average of 62,546.
About Petros Pharmaceuticals Inc
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men’s health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie’s disease, hormone health and substance use disorders.